Nuance Biotech
Latest round
- Series E
Last raised
- Jul 2025
Total raised
- $268M
Investors
- 8
About Nuance Biotech
Founded in 2014 and based in Shanghai, China, Nuance Biotech Inc. operates as a specialty pharmaceutical company that focuses on the research and development of therapeutics. The company's products include Niferex for the treatment of iron deficiency anemia, Fibrin sealant (Human) FIBINGLURAAS for the treatment of the surface of burn and Treanda that supports Rituximab containing regimen.
Who invested in Nuance Biotech
8 investors across 5 rounds
See all investors in Nuance Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nuance Biotech
Who invested in Nuance Biotech?
Nuance Biotech has 8 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nuance Biotech raised?
Nuance Biotech has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Nuance Biotech last raise money?
Nuance Biotech's most recent round on record is a Series E, in Jul 2025.
What does Nuance Biotech do?
Founded in 2014 and based in Shanghai, China, Nuance Biotech Inc.
Where is Nuance Biotech headquartered?
Nuance Biotech is headquartered in Shanghai, China.
Which VCs invest in companies like Nuance Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Nuance Biotech's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Nuance Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.